Wealthfront Advisers LLC Abbott Laboratories Transaction History

Wealthfront Advisers LLC

$29.7 Billion
Q2 2024

A detailed history of Wealthfront Advisers LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Wealthfront Advisers LLC holds 110,555 shares of ABT stock, worth $12.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

110,555

Previous 113,866 2.91%

Holding current value

$12.7 Million

Previous $12.9 Million 11.24%

% of portfolio

0.04%

Previous 0.05%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $333,517 - $372,288	-3,311 Reduced 2.91%	110,555 $11.5 Million
Q1 2024 Apr 19, 2024	BUY	$109.52 - $120.96 $331,845 - $366,508	3,030 Added 2.73%	113,866 $12.9 Million
Q4 2023 Feb 09, 2024	BUY	$90.19 - $110.4 $1.45 Million - $1.78 Million	16,083 Added 16.97%	110,836 $12.2 Million
Q3 2023 Nov 01, 2023	SELL	$95.53 - $114.62 $6.01 Million - $7.21 Million	-62,865 Reduced 39.88%	94,753 $9.18 Million
Q2 2023 Aug 07, 2023	BUY	$100.78 - $112.29 $1.34 Million - $1.49 Million	13,278 Added 9.2%	157,618 $17.2 Million
Q1 2023 Apr 28, 2023	SELL	$96.86 - $114.01 $415,432 - $488,988	-4,289 Reduced 2.89%	144,340 $14.6 Million
Q4 2022 Feb 10, 2023	SELL	$95.06 - $111.52 $1.71 Million - $2.01 Million	-18,024 Reduced 10.82%	148,629 $16.3 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $3.08 Million - $3.57 Million	31,826 Added 23.61%	166,653 $16.1 Million
Q2 2022 Jul 20, 2022	SELL	$102.07 - $123.37 $1.02 Million - $1.23 Million	-10,008 Reduced 6.91%	134,827 $14.6 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $395,991 - $482,885	3,473 Added 2.46%	144,835 $17.1 Million
Q4 2021 Jan 21, 2022	BUY	$115.53 - $141.46 $2.52 Million - $3.08 Million	21,778 Added 18.21%	141,362 $19.9 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $1.92 Million - $2.12 Million	16,421 Added 15.92%	119,584 $14.1 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $841,559 - $990,636	-7,955 Reduced 7.16%	103,163 $12 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $1.24 Million - $1.46 Million	11,359 Added 11.39%	111,118 $13.3 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $269,640 - $293,830	2,568 Added 2.64%	99,759 $10.9 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $192,352 - $233,597	2,099 Added 2.21%	97,191 $10.6 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $892,193 - $1.14 Million	11,652 Added 13.96%	95,092 $8.69 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $746,301 - $1.09 Million	-11,880 Reduced 12.46%	83,440 $6.58 Million
Q4 2019 Jan 21, 2020	BUY	$78.51 - $87.4 $39,255 - $43,700	500 Added 0.53%	95,320 $8.28 Million
Q3 2019 Oct 15, 2019	SELL	$81.84 - $88.74 $70,627 - $76,582	-863 Reduced 0.9%	94,820 $7.93 Million
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $147,144 - $171,615	2,019 Added 2.16%	95,683 $8.05 Million
Q1 2019 May 13, 2019	SELL	$66.22 - $80.06 $160,053 - $193,505	-2,417 Reduced 2.52%	93,664 $7.49 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $6.3 Million - $7.14 Million	96,081 New	96,081 $6.95 Million

Others Institutions Holding ABT

# of Institutions

3,181

Shares Held

1.33B

Call Options Held

8.62M

Put Options Held

7.18M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $202B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthfront Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthfront Advisers LLC with notifications on news.

Account

Wealthfront Advisers LLC Abbott Laboratories Transaction History